Sign in

CIK 0001743881

  • Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,676,804
in 3 filings, $1.7M under 10b5-1 plans

Net −$1,676,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-10-16 HOMCY CHARLES J Chairman of Pharmaceuticals Option exercise · Stock Option (Right to Buy) −10,256 260,207
2020-06-03 HENDERSON MICHAEL THOMAS Chief Business Officer Sale −784 $30.04 $24K 261,399
2020-05-28 KKR Genetic Disorder L.P. 10% owner Sale −2,389,690 $33.39 $79.8M 34,510,971
2019-07-01 KKR Genetic Disorder L.P. 10% owner Conversion +34,253,561 34,253,561
2019-07-01 KKR Genetic Disorder L.P. 10% owner Purchase +2,647,100 $17.00 $45.0M 36,900,661
2019-07-01 KKR Genetic Disorder L.P. 10% owner Conversion · Series B Preferred Units −81,022,727 0
2019-07-01 KKR Genetic Disorder L.P. 10% owner Conversion · Series C Preferred Units −36,246,893 0
2019-07-01 KKR Genetic Disorder L.P. 10% owner Conversion · Series D Preferred Units −50,446,451 0

Page 44 of 44 · 868 trades